4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-18-004307
Options or other derivatives
- Chief Executive Officer acquired 48,795 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PELLETIER SAUNDRA L Chief Executive Officer | 2018-01-17 | Grant or award · Stock Option (right to buy) | +19,249 | 19,249 | D | ||
| PELLETIER SAUNDRA L Chief Executive Officer | 2018-01-17 | Grant or award · Stock Option (right to buy) | +12,833 | 12,833 | D | ||
| PELLETIER SAUNDRA L Chief Executive Officer | 2018-01-17 | Grant or award · Stock Option (right to buy) | +9,994 | 9,994 | D | ||
| PELLETIER SAUNDRA L Chief Executive Officer | 2018-01-17 | Grant or award · Stock Option (right to buy) | +6,719 | 6,719 | D | ||
Loading xslF345X03/doc4.xml…